Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
GBP 50M - 50M
Notice Type:
Contract award notice
Published Date:
06 October 2016
Closing Date:
Location(s):
UK UNITED KINGDOM
Description:

NHS Pharmaceuticals 2016_1

Offer reference number: CM/PHG/12/5378.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months

Potential periods of call-offs under the framework agreement:

CESW: 1.12.2016 to 30.6.2018 (19 months).

LSNE: 1.12.2016 to 31.1.2018 (14 months).

NWLN: 1.12.2016 to 30.6.2017 (7 months).


NHS Pharmaceuticals 2016_1

NHS Pharmaceuticals 2016_1.

Offer reference number: CM/PHG/12/5378.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months.

Potential periods of call-offs under the framework agreement:

Central, South Central and South West: 1.12.2016 to 30.6.2018 (19 months).

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation to Offer Documents for the list of Purchasing Points.


NHS Pharmaceuticals 2016_1

NHS Pharmaceuticals 2016_1 Offer reference number: CM/PHG/12/5378 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months Potential periods of call-offs under the framework agreement: South East, South London, North East and Yorkshire — 1.12.2016 to 31.1.2018 (14 months)

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation to Offer Documents for the list of Purchasing Points.


NHS Pharmaceuticals 2016_1

Invitation to offer for NHS Pharmaceuticals 2016_1.

Offer reference number: CM/PHG/12/5378.

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months.

Potential periods of call-offs under the framework agreement:

Eastern, North London and North West: 1.12.2016 to 30.6.2017 (7 months).

The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation to Offer Documents for the list of Purchasing Points.

Awarded to:
NHS Pharmaceuticals 2016_1
Please see Section VI.3), Please see Section VI.3) (UK)
Download full details as .pdf
The Buyer:
The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)
CPV Code(s):
33600000 - Pharmaceutical products